REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 106 filers reported holding REPLIMUNE GROUP INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,235,627 | -16.1% | 130,662 | +13.9% | 0.00% | 0.0% |
| Q2 2023 | $2,664,216 | +31.8% | 114,738 | +0.2% | 0.00% | 0.0% |
| Q1 2023 | $2,021,840 | -28.4% | 114,487 | +12.3% | 0.00% | -50.0% |
| Q4 2022 | $2,822,855 | +117.2% | 101,977 | +31.2% | 0.00% | +100.0% |
| Q3 2022 | $1,299,760 | -4.5% | 77,725 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $1,360,672 | +1.9% | 77,954 | -0.7% | 0.00% | 0.0% |
| Q1 2022 | $1,334,969 | +200.0% | 78,543 | +387.2% | 0.00% | – |
| Q4 2021 | $445,000 | -5.9% | 16,120 | +1.1% | 0.00% | – |
| Q3 2021 | $473,000 | -20.5% | 15,945 | +3.0% | 0.00% | – |
| Q2 2021 | $595,000 | +38.4% | 15,475 | +9.7% | 0.00% | – |
| Q1 2021 | $430,000 | -21.5% | 14,106 | -1.9% | 0.00% | -100.0% |
| Q4 2020 | $548,000 | +97.8% | 14,374 | +19.5% | 0.00% | – |
| Q3 2020 | $277,000 | +3.0% | 12,033 | +12.1% | 0.00% | – |
| Q2 2020 | $269,000 | – | 10,735 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,001,319 | $51,352,568 | 47.17% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $35,901,913 | 5.56% |
| Redmile Group, LLC | 4,163,922 | $71,244,705 | 3.39% |
| Nan Fung Group Holdings Ltd | 184,739 | $3,160,884 | 2.56% |
| GREAT POINT PARTNERS LLC | 638,495 | $10,924,649 | 1.99% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $2,566,500 | 1.72% |
| Ghost Tree Capital, LLC | 250,000 | $4,277,500 | 1.41% |
| Altium Capital Management LP | 155,000 | $2,652,050 | 1.38% |
| ACUTA CAPITAL PARTNERS, LLC | 1,000 | $1,766,000 | 1.18% |
| Camber Capital Management LP | 2,000,000 | $34,220 | 1.13% |